The company said that it will use the money to support the launch of a minimally invasive test for insulin resistance and risk of diabetes and other chronic diseases.

The BrightKaire test converts stem cells to neurons and exposes those neurons to different antidepressants to determine how ...

As a relatively new subsidiary of SD Biosensor, Meridian is growing its product portfolio within its life sciences and diagnostics businesses.

The test is a bead-based multiplexed immunoassay that also utilizes a machine-learning classifier to determine whether a ...

NEW YORK — Revvity said on Thursday that it has partnered with French drugmaker Sanofi on the development of a test for the early detection of type 1 diabetes (T1D). Revvity currently offers a ...

The Dublin-based digital pathology software firm said that it will use the money for restructuring and commercial expansion in the US and UK.

Wisconsin Physicians Service Insurance Corporation aligned its coverage determination with fellow contractor Palmetto GBA.

The company recently published a study showing that elemental patterns in single strands of hair are different in patients ...

At ASTRO, Artera presented clinical validation data on its prostate cancer test in an Asian population,and showed how the test may complement gene expression-based approaches.

During a talk at the Jefferies Healthcare Services Conference this week, CFO Sam Samad said the business has exceeded the company's expectations.

The test uses mass spectrometry to measure several proteins to assess the likelihood that an individual has the brain amyloid pathology associated with Alzheimer's disease.